Literature DB >> 2887635

Phosphorylation of purified rat striatal tyrosine hydroxylase by Ca2+/calmodulin-dependent protein kinase II: effect of an activator protein.

J Atkinson, N Richtand, C Schworer, R Kuczenski, T Soderling.   

Abstract

The phosphorylation of tyrosine hydroxylase, purified from rat striatum, was investigated using purified Ca2+/calmodulin (CaM)-dependent protein kinase II. This kinase catalyzed the Ca2+-dependent incorporation of up to 0.8 mol 32PO4/mol tyrosine hydroxylase subunit (62 kilodaltons). Reverse-phase high-performance liquid chromatography mapping of tryptic 32P-peptides established that the Ca2+/CaM-dependent protein kinase II phosphorylated a different serine residue than was phosphorylated by the cyclic AMP-dependent protein kinase. Limited proteolysis sequentially reduced the subunit Mr from 62 to 59 kilodaltons and finally to 57 kilodaltons, resulting in loss of the site phosphorylated by the Ca2+/CaM-dependent protein kinase II, but not the site phosphorylated by the cyclic AMP-dependent protein kinase. Phosphorylation by the Ca2+/CaM-dependent protein kinase II had little direct effect on the kinetic properties of tyrosine hydroxylase, but did convert it to a form that could be activated twofold by addition of an activator protein. This heat-labile activator protein increased the Vmax without affecting the Km for the pterin cofactor. This effect was specific in that the activator protein was without effect on nonphosphorylated tyrosine hydroxylase or on tyrosine hydroxylase phosphorylated by the cyclic AMP-dependent protein kinase. These results are consistent with the hypothesis that the "Vmax-type" activation of tyrosine hydroxylase observed upon depolarization of neural and adrenal tissues may be mediated by the Ca2+/CaM-dependent protein kinase II.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2887635     DOI: 10.1111/j.1471-4159.1987.tb10016.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  8 in total

Review 1.  Calcium/calmodulin-dependent protein kinase II.

Authors:  R J Colbran; C M Schworer; Y Hashimoto; Y L Fong; D P Rich; M K Smith; T R Soderling
Journal:  Biochem J       Date:  1989-03-01       Impact factor: 3.857

2.  The phosphorylation of choline acetyltransferase.

Authors:  G Bruce; L B Hersh
Journal:  Neurochem Res       Date:  1989-07       Impact factor: 3.996

3.  Calmodulin and a cyclic nucleotide-dependent protein kinase facilitate the prolactin-induced increase in tyrosine hydroxylase activity in tuberoinfundibular dopaminergic neurons.

Authors:  L A Arbogast
Journal:  Endocrine       Date:  2001-11       Impact factor: 3.633

Review 4.  Structure and function of the aromatic amino acid hydroxylases.

Authors:  S E Hufton; I G Jennings; R G Cotton
Journal:  Biochem J       Date:  1995-10-15       Impact factor: 3.857

5.  Phosphorylation state of tyrosine hydroxylase in the stalk-median eminence is decreased by progesterone in cycling female rats.

Authors:  Bin Liu; Lydia A Arbogast
Journal:  Endocrinology       Date:  2007-12-20       Impact factor: 4.736

6.  Identification by hydrogen/deuterium exchange of structural changes in tyrosine hydroxylase associated with regulation.

Authors:  Shanzhi Wang; Giri R Sura; Lawrence J Dangott; Paul F Fitzpatrick
Journal:  Biochemistry       Date:  2009-06-09       Impact factor: 3.162

7.  ERK1 and ERK2, two microtubule-associated protein 2 kinases, mediate the phosphorylation of tyrosine hydroxylase at serine-31 in situ.

Authors:  J W Haycock; N G Ahn; M H Cobb; E G Krebs
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-15       Impact factor: 11.205

8.  Genetic inhibition of CaMKII in dorsal striatal medium spiny neurons reduces functional excitatory synapses and enhances intrinsic excitability.

Authors:  Jason R Klug; Brian N Mathur; Thomas L Kash; Hui-Dong Wang; Robert T Matthews; A J Robison; Mark E Anderson; Ariel Y Deutch; David M Lovinger; Roger J Colbran; Danny G Winder
Journal:  PLoS One       Date:  2012-09-21       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.